Nuvo Research Inc Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cal Gary who wrote (13452)	5/10/2004 11:30:00 PM
From: Cal Gary	of 14101

For comparision: Novaritis' Lamisil sales in 2003 totalled USD $978 million. Within reach of the magic billion. Lamisil is ranked 4th on Novaritis' revenue generator scale. novartis.com Pharmaceuticals’ Top 10 Products 2003 Change Sales in Change in local USD millions in USD % currencies % Diovan/Co-Diovan 2 425 46 38 Gleevec/Glivec 1 128 84 68 Neoral/Sandimmun 1 020 -2 -10 Lamisil (group) 978 12 5 Zometa 892 83 74 Lotrel 777 20 20 Lescol 734 27 18 Sandostatin (group) 695 15 7 Voltaren (group) 599 1 -6 Cibacen/Lotensin/Cibadrex 433 -6 -9 Every 1% global market share = cool USD $10 million.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next